Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy

Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis

(2016) Hao-Jie Yang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review

(2015) Tze Ping Tan et al.   ANZ JOURNAL OF SURGERY

Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy

(2015) Toshiya Nagasaki et al.   DIGESTIVE SURGERY

The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis

(2015) Ridvan Mercan et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy

(2015) Qing Chen et al.   TUMOR BIOLOGY

Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patients

(2014) Monique Maas et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection

(2014) Kazuo Yamamura et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

(2014) Lijun Shen et al.   Radiation Oncology

Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer

(2014) Ik Yong Kim et al.   BMC Surgery

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

(2013) M Stotz et al.   BRITISH JOURNAL OF CANCER

Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients

(2013) M Pichler et al.   BRITISH JOURNAL OF CANCER

Higher Neutrophil to Lymhocyte Ratio in Patients With Metabolic Syndrome

(2013) Sevket Balta et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer Patients

(2013) Deuk Young Lee et al.   Journal of Gastric Cancer

Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer

(2012) R. Carruthers et al.   Colorectal Disease

Recurrence Rates and Prognostic Factors in ypN0 Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision

(2011) Anand Govindarajan et al.   ANNALS OF SURGICAL ONCOLOGY

Incidence of Coronary Events and Case Fatality Rate in Relation to Blood Lymphocyte and Neutrophil Counts

(2011) Samuel Adamsson Eryd et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy

(2011) Hsin-Yuan Hung et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Generalized Maximally Selected Statistics

(2008) Torsten Hothorn et al.   BIOMETRICS

Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases

(2008) C.P. Neal et al.   EUROPEAN JOURNAL OF CANCER

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE